The main goals of the Ambulatory Chronic Disease CTSU are to address bottlenecks that prevent timely initiation of clinical trials and increase the ability of University of Michigan clinical researchers to compete with peer institutions in trial initiation and recruitment, with the ultimate goal to enhance the culture of clinical research, and to develop the University of Michigan into national leaders in multicenter clinical trials. To achieve these goals, the ACD CTSU will: a) enhance efficiency of the pre-award process by streamlining and reducing the timeline of contract negotiations and regulatory approvals; b) post award support for optimal revenue; c) find best practices of clinical research and promote their implementation by all CTSU members; d) continue supporting research clusters with a track record of success; e) provide mentorship and pre- and post-award resources to funded junior faculty who would embark on a mentored clinical research program. The CTSU also has faculty with extensive experience in launching multicenter clinical trials that can be used as a resource for CTSU members. The CTSU is the home for all chronic, non-ICU diseases in the adult population, excluding cancer and cardiovascular disease, which constitute the majority of clinical trials in the ambulatory Internal Medicine divisions and Department of Ophthalmology & Visual Sciences. Divisions involved include rheumatology, endocrinology, pulmonary medicine, geriatrics, nephrology, and gastroenterology, along with the Department of Ophthalmology, which account for a large number of the ambulatory trials within UMHS.
Faculty & Staff
- Amy Oliver, Finance Team Lead, firstname.lastname@example.org, 734-998-9993
- Liz VanderElzen, Contract & Grant Specialist, email@example.com, 734-764-9687
- Elizabeth Wu, Clinical Research Project Manager, firstname.lastname@example.org, 734-998-9992
- Jason Yunk, Grant and Contract Specialist, email@example.com, 734-764-8922